GB1423244A - Dilution agent - Google Patents
Dilution agentInfo
- Publication number
- GB1423244A GB1423244A GB4780473A GB4780473A GB1423244A GB 1423244 A GB1423244 A GB 1423244A GB 4780473 A GB4780473 A GB 4780473A GB 4780473 A GB4780473 A GB 4780473A GB 1423244 A GB1423244 A GB 1423244A
- Authority
- GB
- United Kingdom
- Prior art keywords
- salt
- buffer solution
- alkali metal
- oct
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
1423244 Buffer solution F HOFFMANNLA ROCHE & CO A G 12 Oct 1973 [13 Oct 1972] 47804/73 Heading G1B An aqueous buffer solution having a pH of about 6À5 comprises per litre a salt of an organic acid with an alkali metal in an amount which is the mole equivalent of about 1À3 gms per litre of the disodium salt of ethylene diamine tetra acetic acid dihydrate, a preservative and an alkali metal hydroxide. The alkali metal of the salt is perferably the same as that of the hydroxide, and is suitably sodium. The salt is preferably the disodium salt of ethylene diamine tetra acetic acid dihydrate. A suitable preservative is sodium azide. There may also be present a proteinaceous material inert to CEA (carcinoembryonic antigen) antibody-antigen reactions, such as bovine serum albumin. The aqueous buffer solution may be prepared by diluting a concentrate of the ingredients with deionized or distilled water. The buffer solution may be used as a substitute for plasma extract in the preparation of antiserum titration curves and standard antigen inhibition curves.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00297565A US3852415A (en) | 1972-10-13 | 1972-10-13 | Compositions for use in radioimmunoassay as a substitute for blood plasma extract in determination of carcinoembryonic antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1423244A true GB1423244A (en) | 1976-02-04 |
Family
ID=23146844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4780473A Expired GB1423244A (en) | 1972-10-13 | 1973-10-12 | Dilution agent |
Country Status (15)
Country | Link |
---|---|
US (1) | US3852415A (en) |
JP (1) | JPS5315130B2 (en) |
AU (1) | AU467511B2 (en) |
BE (1) | BE805991A (en) |
CA (1) | CA1012458A (en) |
CH (1) | CH584409A5 (en) |
DD (1) | DD108151A5 (en) |
DE (1) | DE2349738C3 (en) |
FR (1) | FR2203525A5 (en) |
GB (1) | GB1423244A (en) |
IL (1) | IL43378A (en) |
IT (1) | IT1001584B (en) |
NL (1) | NL161884C (en) |
SE (1) | SE417460B (en) |
ZA (2) | ZA723264B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0207633A2 (en) * | 1985-06-03 | 1987-01-07 | Erika, Inc. | Sterilant compositions |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3901870A (en) * | 1974-03-12 | 1975-08-26 | Behringwerke Ag | Derivative of alpha' 1'-fetospecific serum protein and process for its manufacture |
US4132769A (en) * | 1974-10-30 | 1979-01-02 | Osther Kurt B | Cancer antigen, cancer therapy, and cancer diagnosis |
US3999944A (en) * | 1975-02-28 | 1976-12-28 | Hoffmann-La Roche Inc. | Detection of breast cancer |
US4043757A (en) * | 1975-05-20 | 1977-08-23 | Ortho Pharmaceutical Corporation | Method for detection of human mammary carcinoma |
US4152410A (en) * | 1975-09-03 | 1979-05-01 | Eisai Co., Ltd. | Diagnosis reagent for neoplasm and method for diagnosis of neoplasm |
US4379839A (en) * | 1977-05-23 | 1983-04-12 | The Trustees Of Columbia University In The City Of New York | Method for detecting cancer |
JPS562557A (en) * | 1979-06-22 | 1981-01-12 | Green Cross Corp:The | Aqueous solvent for coagulation test |
US4349528A (en) * | 1979-11-21 | 1982-09-14 | The Wistar Institute | Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen |
JPS57208459A (en) * | 1981-06-19 | 1982-12-21 | Eisai Co Ltd | Measuring method using enzyme-labelled antibody and reagent |
US4631254A (en) * | 1982-12-06 | 1986-12-23 | Hoffmann-La Roche Inc. | Carcinoembryonic antigen determination |
US4624916A (en) * | 1984-04-06 | 1986-11-25 | International Immunoassay Laboratories, Inc. | Process and composition for the rapid quantitation of small levels of creative kinase-MB isoenzyme |
JPS61280566A (en) * | 1984-09-03 | 1986-12-11 | Hiroaki Sawai | Direct immunoassay of 2'-5'-oligoadenylic acid |
US6013772A (en) * | 1986-08-13 | 2000-01-11 | Bayer Corporation | Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays |
CA1296253C (en) * | 1986-10-20 | 1992-02-25 | Praveen Tyle | Stabilized growth hormone compositions |
US5296377A (en) * | 1992-12-15 | 1994-03-22 | Boehringer Mannheim Corporation | Control reagent containing a hydroxylamine or an antioxidant |
CN102905562A (en) | 2010-05-20 | 2013-01-30 | 艺康美国股份有限公司 | Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof |
KR102384708B1 (en) * | 2020-06-19 | 2022-04-11 | 대한민국 | Artificial blood for bloodstain pattern analysis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3720760A (en) * | 1968-09-06 | 1973-03-13 | Pharmacia Ab | Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples |
US3697638A (en) * | 1970-06-01 | 1972-10-10 | Hoffmann La Roche | Antigens |
-
1972
- 1972-05-15 ZA ZA723264A patent/ZA723264B/en unknown
- 1972-10-13 US US00297565A patent/US3852415A/en not_active Expired - Lifetime
-
1973
- 1973-10-01 CH CH1403573A patent/CH584409A5/xx not_active IP Right Cessation
- 1973-10-01 ZA ZA737693A patent/ZA737693B/en unknown
- 1973-10-02 CA CA182,470A patent/CA1012458A/en not_active Expired
- 1973-10-03 DE DE2349738A patent/DE2349738C3/en not_active Expired
- 1973-10-04 IL IL43378A patent/IL43378A/en unknown
- 1973-10-08 IT IT29875/73A patent/IT1001584B/en active
- 1973-10-10 AU AU61242/73A patent/AU467511B2/en not_active Expired
- 1973-10-11 FR FR7336328A patent/FR2203525A5/fr not_active Expired
- 1973-10-12 DD DD174034A patent/DD108151A5/xx unknown
- 1973-10-12 GB GB4780473A patent/GB1423244A/en not_active Expired
- 1973-10-12 SE SE7313919A patent/SE417460B/en unknown
- 1973-10-12 BE BE136609A patent/BE805991A/en not_active IP Right Cessation
- 1973-10-12 JP JP11463773A patent/JPS5315130B2/ja not_active Expired
- 1973-10-12 NL NL7314093.A patent/NL161884C/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0207633A2 (en) * | 1985-06-03 | 1987-01-07 | Erika, Inc. | Sterilant compositions |
EP0207633A3 (en) * | 1985-06-03 | 1987-05-06 | National Medical Care | Sterilant compositions |
US4690772A (en) * | 1985-06-03 | 1987-09-01 | National Medical Care | Sterilant compositions |
Also Published As
Publication number | Publication date |
---|---|
DE2349738A1 (en) | 1974-04-18 |
FR2203525A5 (en) | 1974-05-10 |
IL43378A0 (en) | 1974-01-14 |
SE417460B (en) | 1981-03-16 |
ZA723264B (en) | 1974-08-28 |
JPS5315130B2 (en) | 1978-05-23 |
DE2349738C3 (en) | 1981-06-19 |
BE805991A (en) | 1974-04-12 |
NL7314093A (en) | 1974-04-16 |
US3852415A (en) | 1974-12-03 |
NL161884C (en) | 1980-03-17 |
IL43378A (en) | 1976-04-30 |
CH584409A5 (en) | 1977-01-31 |
NL161884B (en) | 1979-10-15 |
AU467511B2 (en) | 1975-12-04 |
JPS4971133A (en) | 1974-07-10 |
CA1012458A (en) | 1977-06-21 |
IT1001584B (en) | 1976-04-30 |
ZA737693B (en) | 1974-08-28 |
DD108151A5 (en) | 1974-09-05 |
AU6124273A (en) | 1975-05-01 |
DE2349738B2 (en) | 1978-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1423244A (en) | Dilution agent | |
GB1132474A (en) | Method for the preparation of thiogold (i) compounds | |
GB1192314A (en) | A Process for dissolving Insoluble Collagen | |
FI960327A0 (en) | Process for the preparation of aluminum salt solutions | |
GB1252781A (en) | Composition of matter for limiting dehydration and fatigue during periods of physical exertion | |
SE8900828D0 (en) | ANTIVIRAL AND IMMUNSTIMULATING PHARMACEUTICAL COMPOSITIONS AND PROCEDURES FOR PREPARING THEM | |
ES360433A1 (en) | Iron composition for treating anemia | |
ES2000089A6 (en) | Conjugated reagent for an enzyme immunoassay. | |
FR2375341A1 (en) | CORROSION INHIBITOR FOR ALUMINUM IN ALKALINE SOLUTIONS | |
GB1442772A (en) | Inhibition of leukaemia utilizing 5-methyl-tetrahydrohomofolate | |
GB1533906A (en) | Process for reducing the water sensitivity of polyvinyl alcohol | |
ES541054A0 (en) | A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION INCLUDING AZAPROPANONE | |
GB748024A (en) | Improved therapeutic preparations of iron | |
AU3527684A (en) | Succinic acid mono-dialkylamides as water-soluble corrosion inhibitors | |
FR2424919A1 (en) | SUBSTITUTE QUINOLEINECARBOXYLIC ACID AND ITS DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | |
GB1243252A (en) | Stable poliomyelitis vaccines and process for their manufacture | |
MX9207225A (en) | L-SINE CARBOXYMETHYLCISTEINE SALT MONOHYDRATE AND PROCESS FOR ITS PREPARATION. | |
GB643268A (en) | Improved process for the preparation of prolonged effect insulin products | |
IE37143L (en) | Citric acid | |
AU534886B2 (en) | Solutions of canrenoic acid and furosemide salts | |
GB1292832A (en) | Developing composition | |
ES2082159T3 (en) | HYDRO-SOLUBLE THIOUREA DERIVATIVES AND PROCEDURE FOR ITS PREPARATION. | |
Owen et al. | Na/K/Cl cotransport in cultured human fibroblasts. | |
GB1282906A (en) | Alkali metal hypochlorite solutions | |
GB1173004A (en) | Process for Treating Hair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |